You searched for metabolic diseases - Page 46 of 63

inflammatory disease imperial college london macrophage

News and Trends 12 Jul 2017

British Researchers “Calm Down” Macrophages to treat Inflammation

…to humans in order to restore normal metabolism in many inflammatory diseases. However, given the early stage of the study, more information is needed before that. Behmoaras wants to study…

July 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Jan 2020

T-Cell Discovery Could Herald Universal Cancer Immunotherapy

…T-cells (red) attacking a cancer cell (white). A key aspect of MR1 is that the protein reveals the metabolic ‘signature’ of the cell that is being scanned by the immune…

January 21, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 4 Nov 2022

EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease

…spectrum of cardiovascular, kidney or metabolic conditions. The trial assessed both kidney and cardiovascular outcomes in people across the spectrum of CKD severity. “The Boehringer Ingelheim and Lilly Alliance is incredibly proud…

November 4, 2022 - 4 minutesmins - By Liza Laws

Scenic biotech lysosomal storage disorders

News and Trends 10 Mar 2022

Emerging Startups Take Aim at Lysosomal Storage Disorders

…to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading to the buildup of toxic…

March 10, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 5 Apr 2016

Israeli Cancer Startup catches Investment from 3 major Big Pharma

…new genes that form a ‘synthetic lethal gene pair’ with metabolic genes (inactivated in cancer cells) – making cancer cells non-viable. Fig 1: The concept behind synthetic lethality. A gene…

April 5, 2016 - 3 minutesmins - By Denise Neves Gameiro

Expert Advice 6 Feb 2020

Why a Big Pharma Background Can Give Biotech Leaders an Edge

…disease, but will die of cardiovascular diseases. Most patients have metabolic syndrome and are at high risk for cardiovascular disease. Besides that, you also see more activity around triglyceride-lowering treatments…

February 6, 2020 - 11 minutesmins - By Helen Albert

genfit ceo mouney liver disease NASH elafibranor interview

News and Trends 16 Nov 2015

Interview with the CEO of Genfit – The Billion Euro Liver Biotech on its phase III NASH Drug

…even improved cardiometabolic protection. These two elements are crucial in the fight against NASH: this is why we are supported by Key Opinion Leaders of the scientific/medical community. NASH is…

November 16, 2015 - 5 minutesmins - By Dani Bancroft

seventure microbiome labiotech biotech fund eligo enterome microbiomics medicine

News and Trends 16 May 2016

Interviewing the Founder of the World #1 Microbiome Investment fund

…targeting the link between Neurological disease and intestinal health. The goal is to treat patients with eating disorders and metabolic deregulation (from Obesity to anorexia and cachexia). They also published…

May 16, 2016 - 4 minutesmins - By Philip Hemme

Best in Biotech 12 Jun 2023

Six advancements in Alzheimer’s research over the past year

…not interfere with other cyclin-dependent kinases – enzymes that regulate the cell cycle. As P25 has been linked to multiple neurodegenerative diseases, this could be a therapeutic breakthrough for conditions…

June 12, 2023 - 12 minutesmins - By Roohi Mariam Peter

News and Trends 11 Aug 2022

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

…with programs ranging from pre-clinical to registration studies. SBP-101 is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition by exploiting an observed high affinity of the compound for…

August 11, 2022 - 3 minutesmins - By Liza Laws

young researchers entrepreneurs biotech europe 1

Best in Biotech 4 Apr 2017

Top Young Researchers Making Names for Themselves in Industry

…with an industrial yeast strain through metabolic engineering. Anastasia Krivoruchko After finishing her PhD at Carleton University, Canada, Anastasia Krivoruchko went on to do a postdoc at Chalmers University of…

April 4, 2017 - 4 minutesmins - By Denise Neves Gameiro

Best in Biotech 3 Oct 2023

Five impactful biotech companies to know in New York

…targeting diseases such as depression, Alzheimer’s disease agitation, migraine, narcolepsy, and fibromyalgia. In Just last year, the U.S. Food and Drug Administration (FDA) approved Axsome’s drug Auvelity (dextromethorphan HBr -bupropion…

October 3, 2023 - 8 minutesmins - By Willow Shah-Neville

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

British Researchers “Calm Down” Macrophages to treat Inflammation

T-Cell Discovery Could Herald Universal Cancer Immunotherapy

EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease

Emerging Startups Take Aim at Lysosomal Storage Disorders

Israeli Cancer Startup catches Investment from 3 major Big Pharma

Why a Big Pharma Background Can Give Biotech Leaders an Edge

Interview with the CEO of Genfit – The Billion Euro Liver Biotech on its phase III NASH Drug

Interviewing the Founder of the World #1 Microbiome Investment fund

Six advancements in Alzheimer’s research over the past year

First patient enrolled on Panbela’s trial for treatment of pancreatic cancer

Top Young Researchers Making Names for Themselves in Industry

Five impactful biotech companies to know in New York

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!